Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

WHO a step closer to innovation strategy for developing world:

This article was originally published in Clinica

Executive Summary

The World Health Organization's Intergovernmental Working Group on Public Health, Innovation and Intellectual Property is sounding confident that a strategy to improve access to healthcare products in the developing world will be reached in May 2008. At the end of a six-day roundtable involving representatives from 140 countries, it says it has made significant progress on "agreeing the basic principles underlying the effort, as well as on some specific elements of the strategy". However, R&D, innovative capacity in the developing world, intellectual property rights and sustainable financing are still described as "difficult and complex issues" in the negotiations. The talks aimed at finalising the strategy and action plan are scheduled to resume on April 28 2008, ahead of the WHO's annual meeting in May.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT050175

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel